Nextcure to participate in the 36th annual piper sandler healthcare conference

Beltsville, md., nov. 26, 2024 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will participate in a fireside chat at the 36th annual piper sandler healthcare conference in new york city on thursday, december 5, at 12:00 pm et.
NXTC Ratings Summary
NXTC Quant Ranking